PROM1 and malignant colon neoplasm: (ii) Relevant findings: 89Zr-CD133 IgG showed CD133-dependent specific binding to HT29 colon cancer cells, displayed favorable in vivo pharmacokinetics and biodistribution, and provided high-contrast PET imaging of HT29 tumors.